Human herpesvirus 8 - A novel human pathogen

Virology Journal

Volumn 2, Issue , 2005, Pages

  Edelman, Daniel C ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; CIDOFOVIR; FOSCARNET; GANCICLOVIR; GLYCOPROTEIN; NEUTRALIZING ANTIBODY;

ANGIOFOLLICULAR LYMPH NODE HYPERPLASIA; BETAHERPESVIRINAE; BIOLOGY; CHEMOTHERAPY; COMPARATIVE STUDY; CYTOLOGY; DIAGNOSTIC PROCEDURE; DNA SYNTHESIS; GENE EXPRESSION; GENE STRUCTURE; GENOMICS; GENOTYPE; HERPES VIRUS; HUMAN HERPESVIRUS 8; IMMUNE RESPONSE; INFECTION; KAPOSI SARCOMA; MULTIPLE MYELOMA; NONHUMAN; PATHOGENESIS; PHENOTYPE; PREVALENCE; PRIMARY EFFUSION LYMPHOMA; REVIEW; SARCOIDOSIS; SEQUENCE HOMOLOGY; SERODIAGNOSIS; SEXUAL TRANSMISSION; TRANSPLANTATION; VIRAL GENETICS; VIRUS CLASSIFICATION; VIRUS INFECTION; VIRUS TRANSMISSION; WESTERN BLOTTING; ANTIBODY PRODUCTION; CELLULAR IMMUNITY; HERPES VIRUS INFECTION; HUMAN; IMMUNOLOGY; INNATE IMMUNITY; PATHOGENICITY; PHYSIOLOGY; VIROLOGY; VIRUS GENE; VIRUS GENOME;

HERPESVIRIDAE; HUMAN HERPESVIRUS 8;

ANTIBODY FORMATION; GENES, VIRAL; GENOME, VIRAL; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 8, HUMAN; HUMANS; IMMUNITY, CELLULAR; IMMUNITY, INNATE; SARCOMA, KAPOSI;

EID: 26244451394     PISSN: 1743422X     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-2-78     Document Type: Review

References (295)

1. Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, Knowles DM, Moore PS: Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 1994, 266(5192):1865-1869.
2. Knipe DM, Howley PM: Fields Virology. Volume 1. 4th edition. Philadelphia: Lippincott Williams & Wilkins; 2001.
3. Moore PS, Chang Y: Molecular virology of Kaposi's sarcoma-associated herpesvirus. Philosophical Transactions of the Royal Society of London - Series B: Biological Sciences 2001, 356(1408):499-516.
4. Mesri EA, Cesarman E, Arvanitakis L, Rafii S, Moore MA, Posnett DN, Knowles DM, Asch AS: Human herpesvirus-8/Kaposi's sarcoma-associated herpesvirus is a new transmissible virus that infects B cells. J Exp Med 1996, 183(5):2385-2390.
5. Neipel F, Albrecht JC, Fleckenstein B: Human herpesvirus 8 - the first human Rhadinovirus. Journal of the National Cancer Institute Monographs 1998:73-77.
6. Furlong D, Swift H, Roizman B: Arrangement of herpesvirus deoxyribonucleic acid in the core. Journal of Virology 1972, 10(5):1071-1074.
7. Wu L, Lo P, Yu X, Stoops JK, Forghani B, Zhou ZH: Three-dimensional structure of the human herpesvirus 8 capsid. J Virol 2000, 74(20):9646-9654.
8. Renne R, Zhong W, Herndier B, McGrath M, Abbey N, Kedes D, Ganem D: Lytic growth of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in culture. Nat Med 1996, 2(3):342-346.
9. Walter PR, Philippe E, Nguemby-Mbina C, Chamlian A: Kaposi's sarcoma: presence of herpes-type virus particles in a tumor specimen. Human Pathology 1984, 15(12):1145-1146.
10. McCombs RM, Brunschwig JP, Mirkovic R, Benyesh-Melnick M: Electron microscopic characterization of a herpeslike virus isolated from tree shrews. Virology 1971, 45(3):816-820.
11. Epstein MA: Observations on the mode of release of herpes virus from infected HeLa cells. Journal of Cell Biology 1962, 12:589-597.
12. Morgan C, Rose HM, Mednis B: Electron microscopy of herpes simplex virus. I. Entry. Journal of Virology 1968, 2(5):507-516.
13. Asher Y, Heller M, Becker Y: Incorporation of lipids into herpes simplex virus particles. Journal of General Virology 1969, 4(1):65-76.
14. Deiss LP, Chou J, Frenkel N: Functional domains within the a sequence involved in the cleavage-packaging of herpes simplex virus DNA. Journal of Virology 1986, 59(3):605-618.
15. Markovitz NS, Filatov F, Roizman B: The U(L)3 protein of herpes simplex virus 1 is translated predominantly from the second in-frame methionine codon and is subject to at least two posttranslational modifications. Journal of Virology 1999, 73(10):8010-8018.
16. Lennette ET, Blackbourn DJ, Levy JA: Antibodies to human herpesvirus type 8 in the general population and in Kaposi's sarcoma patients. Lancet 1996, 348(9031):858-861.
17. Renne R, Lagunoff M, Zhong W, Ganem D: The size and conformation of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) DNA in infected cells and virions. J Virol 1996, 70(11):8151-8154.
18. Moore PS, Gao SJ, Dominguez G, Cesarman E, Lungu O, Knowles DM, Garber R, Pellett PE, McGeoch DJ, Chang Y: Primary characterization of a herpesvirus agent associated with Kaposi's sarcomae [published erratum appears in J Virol 1996 Dec;70(12):9083]. J Virol 1996, 70(1):549-558.
19. Russo JJ, Bohenzky RA, Chien MC, Chen J, Yan M, Maddalena D, Parry JP, Peruzzi D, Edelman IS, Chang Y, et al.: Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8). Proc Natl Acad Sci U S A 1996, 93(25):14862-14867.
20. Arvanitakis L, Geras-Raaka E, Varma A, Gershengorn MC, Cesarman E: Human herpesvirus KSHV encodes a constitutively active G-protein-coupled receptor linked to cell proliferation. Nature 1997, 385(6614):347-350.
21. Coscoy L, Ganem D: Kaposi's sarcoma-associated herpesvirus encodes two proteins that block cell surface display of MHC class I chains by enhancing their endocytosis. Proc Natl Acad Sci U S A 2000, 97(14):8051-8056.
22. Sarid R, Flore O, Bohenzky RA, Chang Y, Moore PS: Transcription mapping of the Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) genome in a body cavity-based lymphoma cell line (BC-1). J Virol 1998, 72(2):1005-1012.
23. Cesarman E, Chang Y, Moore PS, Said JW, Knowles DM: Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N Engl J Med 1995, 332(18):1186-1191.
24. Sturzl M, Blasig C, Schreier A, Neipel F, Hohenadl C, Cornali E, Ascherl G, Esser S, Brockmeyer NH, Ekman M, et al.: Expression of HHV-8 latency-associated T0.7 RNA in spindle cells and endothelial cells of AIDS-associated, classical and African Kaposi's sarcoma. Int J Cancer 1997, 72(1):68-71.
25. Renne R, Blackbourn D, Whitby D, Levy J, Ganem D: Limited transmission of Kaposi's sarcoma-associated herpesvirus in cultured cells. J Virol 1998, 72(6):5182-5188.
26. Ambroziak JA, Blackbourn DJ, Herndier BG, Glogau RG, Gullett JH, McDonald AR, Lennette ET, Levy JA: Herpes-like sequences in HIV-infected and uninfected Kaposi's sarcoma patients [letter; comment]. Science 1995, 268(5210):582-583.
27. Boshoff C, Schulz TF, Kennedy MM, Graham AK, Fisher C, Thomas A, McGee JO, Weiss RA, O'Leary JJ: Kaposi's sarcoma-associated herpesvirus infects endothelial and spindle cells. Nat Med 1995, 1(12):1274-1278.
28. Blasig C, Zietz C, Haar B, Neipel F, Esser S, Brockmeyer NH, Tschachler E, Colombini S, Ensoli B, Sturzl M: Monocytes in Kaposi's sarcoma lesions are productively infected by human herpesvirus 8. J Virol 1997, 71(10):7963-7968.
29. Diamond C, Brodie SJ, Krieger JN, Huang ML, Koelle DM, Diem K, Muthui D, Corey L: Human herpesvirus 8 in the prostate glands of men with Kaposi's sarcoma. J Virol 1998, 72(7):6223-6227.
30. Corbellino M, Parravicini C, Aubin JT, Berti E: Kaposi's sarcoma and herpesvirus-like DNA sequences in sensory ganglia [letter]. N Engl J Med 1996, 334(20):1341-1342.
31. Horwitz CA, Henle W, Henle G, Snover D, Rudnick H, Balfour HH Jr, Mazur MH, Watson R, Schwartz B, Muller N: Clinical and laboratory evaluation of cytomegalovirus-induced mononucleosis in previously healthy individuals. Report of 82 cases. Medicine 1986, 65(2):124-134.
32. Manual of Clinical Microbiology. .
33. Evans AS, Niederman JC, Cenabre LC, West B, Richards VA: A prospective evaluation of heterophile and Epstein-Barr virus-specific IgM antibody tests in clinical and subclinical infectious mononucleosis: Specificity and sensitivity of the tests and persistence of antibody. Journal of Infectious Diseases 1975, 132(5):546-554.
34. Ablashi D, Chatlynne L, Cooper H, Thomas D, Yadav M, Norhanom AW, Chandana AK, Churdboonchart V, Kulpradist SA, Patnaik M, et al.: Seroprevalence of human herpesvirus-8 (HHV-8) in countries of Southeast Asia compared to the USA, the Caribbean and Africa. Br J Cancer 1999, 81(5):893-897.
35. Svahn A, Magnusson M, Jagdahl L, Schloss L, Kahlmeter G, Linde A: Evaluation of three commercial enzyme-linked immunosorbent assays and two latex agglutination assays for diagnosis of primary Epstein-Barr virus infection. Journal of Clinical Microbiology 1997, 35(11):2728-2732.
36. Buisson M, Fleurent B, Mak M, Morand P, Chan L, Ng A, Guan M, Chin D, Seigneurin JM: Novel immunoblot assay using four recombinant antigens for diagnosis of Epstein-Barr virus primary infection and reactivation. Journal of Clinical Microbiology 1999, 37(8):2709-2714.
37. Sixbey JW, Yao QY: Immunoglobulin A-induced shift of Epstein-Barr virus tissue tropism. Science 1992, 255(5051):1578-1580.
38. Henle W, Henle G, Andersson J, Ernberg I, Klein G, Horwitz CA, Marklund G, Rymo L, Wellinder C, Straus SE: Antibody responses to Epstein-Barr virus-determined nuclear antigen (EBNA)-1 and EBNA-2 in acute and chronic Epstein-Barr virus infection. Proceedings of the National Academy of Sciences of the United States of America 1987, 84(2):570-574.
39. Meij P, Vervoort MB, Aarbiou J, van Dissel P, Brink A, Bloemena E, Meijer CJ, Middeldorp JM: Restricted low-level human antibody responses against Epstein-Barr virus (EBV)-encoded latent membrane protein 1 in a subgroup of patients with EBV-associated diseases. Journal of Infectious Diseases 1999, 179(5):1108-1115.
40. Arvin AM, Koropchak CM: Immunoglobulins M and G to varicella-zoster virus measured by solid-phase radioimmunoassay: antibody responses to varicella and herpes zoster infections. Journal of Clinical Microbiology 1980, 12(3):367-374.
41. Dialyna IA, Graham D, Rezaee R, Blue CE, Stavrianeas NG, Neisters HG, Spandidos DA, Blackbourn DJ: Anti-HHV-8/KSHV antibodies in infected individuals inhibit infection in vitro. AIDS 2004, 18(9):1263-1270.
42. Kimball LE, Casper C, Koelle DM, Morrow R, Corey L, Vieira J: Reduced levels of neutralizing antibodies to Kaposi sarcoma-associated herpesvirus in persons with a history of Kaposi sarcoma. Journal of Infectious Diseases 2004, 189(11):2016-2022.
43. Inoue N, Spira T, Lam L, Corchero JL, Luo W: Comparison of serologic responses between Kaposi's sarcoma-positive and -negative men who were seropositive for both human herpesvirus 8 and human immunodeficiency virus. Journal of Medical Virology 2004, 74(2):202-206.
44. Wang QJ, Jenkins FJ, Jacobson LP, Kingsley LA, Day RD, Zhang ZW, Meng YX, Pellet PE, Kousoulas KG, Baghian A, et al.: Primary human herpesvirus 8 infection generates a broadly specific CD8(+) T-cell response to viral lytic cycle proteins. Blood 2001, 97(8):2366-2373.
45. Osman M, Kubo T, Gill J, Neipel F, Becker M, Smith G, Weiss R, Gazzard B, Boshoff C, Gotch F: Identification of human herpesvirus 8-specific cytotoxic T-cell responses. J Virol 1999, 73(7):6136-6140.
46. Goudsmit J, Renwick N, Dukers NH, Coutinho RA, Heisterkamp S, Bakker M, Schulz TF, Cornelissen M, Weverling GJ: Human herpesvirus 8 infections in the Amsterdam Cohort Studies (1984-1997): analysis of seroconversions to ORF65 and ORF73. Proc Natl Acad Sci U S A 2000, 97(9):4838-4843.
47. Sirianni MC, Vincenzi L, Topino S, Giovannetti A, Mazzetta F, Libi F, Scaramuzzi D, Andreoni M, Pinter E, Baccarini S, et al.: NK cell activity controls human herpesvirus 8 latent infection and is restored upon highly active antiretroviral therapy in AIDS patients with regressing Kaposi's sarcoma. European Journal of Immunology 2002, 32(10):2711-2720.
48. Monini P, Colombini S, Sturzl M, Goletti D, Cafaro A, Sgadari C, Butto S, Franco M, Leone P, Fais S, et al.: Reactivation and persistence of human herpesvirus-8 infection in B cells and monocytes by Th-1 cytokines increased in Kaposi's sarcoma. Blood 1999, 93(12):4044-4058.
49. Luppi M, Barozzi P, Schulz TF, Trovato R, Donelli A, Narni F, Sheldon J, Marasca R, Torelli G: Nonmalignant disease associated with human herpesvirus 8 reactivation in patients who have undergone autologous peripheral blood stem cell transplantation. Blood 2000, 96(7):2355-2357.
50. LaDuca JR, Love JL, Abbott LZ, Dube S, Freidman-Kien AE, Poiesz BJ: Detection of human herpesvirus 8 DNA sequences in tissues and bodily fluids. J Infect Dis 1998, 178(6):1610-1615.
51. Koelle DM, Huang ML, Chandran B, Vieira J, Piepkorn M, Corey L: Frequent detection of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) DNA in saliva of human immunodeficiency virus-infected men: clinical and immunologic correlates. J Infect Dis 1997, 176(1):94-102.
52. Howard MR, Whitby D, Bahadur G, Suggett F, Boshoff C, Tenant-Flowers M, Schulz TF, Kirk S, Matthews S, Weller IV, et al.: Detection of human herpesvirus 8 DNA in semen from HIV-infected individuals but not healthy semen donors. AIDS 1997, 11(2):F15-19.
53. Grandadam M, Dupin N, Calvez V, Gorin I, Blum L, Kernbaum S, Sicard D, Buisson Y, Agut H, Escande JP, et al.: Exacerbations of clinical symptoms in human immunodeficiency virus type 1-infected patients with multicentric Castleman's disease are associated with a high increase in Kaposi's sarcoma herpesvirus DNA load in peripheral blood mononuclear cells. J Infect Dis 1997, 175(5):1198-1201.
54. Harrington WJ Jr, Bagasra O, Sosa CE, Bobroski LE, Baum M, Wen XL, Cabral L, Byrne GE, Pomerantz RJ, Wood C: Human herpesvirus type 8 DNA sequences in cell-free plasma and mononuclear cells of Kaposi's sarcoma patients. J Infect Dis 1996, 174(5):1101-1105.
55. Whitby D, Howard MR, Tenant-Flowers M, Brink NS, Copas A, Boshoff C, Hatzioannou T, Suggett FE, Aldam DM, Denton AS, et al.: Detection of Kaposi sarcoma associated herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposi's sarcoma. Lancet 1995, 346(8978):799-802.
56. Pauk J, Huang ML, Brodie SJ, Wald A, Koelle DM, Schacker T, Celum C, Selke S, Corey L: Mucosal shedding of human herpesvirus 8 in men. N Engl J Med 2000, 343(19):1369-1377.
57. Camera Pierrotti L, Masami Sumita L, Santos Freire W, Hehl Caiaffa Filho H, Akico Ueda Fick de Souza V: Detection of human herpesvirus 8 DNA and antibodies to latent nuclear and lytic-phase antigens in serial samples from aids patients with Kaposi's sarcoma. J Clin Virol 2000, 16(3):247-251.
58. Blackbourn DJ, Ambroziak J, Lennette E, Adams M, Ramachandran B, Levy JA: Infectious human herpesvirus 8 in a healthy North American blood donor. Lancet 1997, 349(9052):609-611.
59. Simpson GR, Schulz TF, Whitby D, Cook PM, Boshoff C, Rainbow L, Howard MR, Gao SJ, Bohenzky RA, Simmonds P, et al.: Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen. Lancet 1996, 348(9035):1133-1138.
60. Smith MS, Bloomer C, Horvat R, Goldstein E, Casparian JM, Chandran B: Detection of human herpesvirus 8 DNA in Kaposi's sarcoma lesions and peripheral blood of human immunodeficiency virus-positive patients and correlation with serologic measurements. J Infect Dis 1997, 176(1):84-93.
61. Angeloni A, Heston L, Uccini S, Sirianni MC, Cottoni F, Masala MV, Cerimele D, Lin SF, Sun R, Rigsby M, et al.: High prevalence of antibodies to human herpesvirus 8 in relatives of patients with classic Kaposi's sarcoma from Sardinia. J Infect Dis 1998, 177(6):1715-1718.
62. Campbell TB, Borok M, Gwanzura L: HHV-8 peripheral-blood viral load and the titer of antibodies against HHV-8 [letter; comment]. N Engl J Med 1999, 341(16):1241-1242.
63. Moore PS, Boshoff C, Weiss RA, Chang Y: Molecular mimicry of human cytokine and cytokine response pathway genes by KSHV. Science 1996, 274(5293):1739-1744.
64. Burger R, Neipel F, Fleckenstein B, Savino R, Ciliberto G, Kalden JR, Gramatzki M: Human herpesvirus type 8 interleukin-6 homologue is functionally active on human myeloma cells. Blood 1998, 91(6):1858-1863.
65. Staskus KA, Sun R, Miller G, Racz P, Jaslowski A, Metroka C, Brett-Smith H, Haase AT: Cellular tropism and viral interleukin-6 expression distinguish human herpesvirus 8 involvement in Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease. J Virol 1999, 73(5):4181-4187.
66. Parravinci C, Corbellino M, Paulli M, Magrini U, Lazzarino M, Moore PS, Chang Y: Expression of a virus-derived cytokine, KSHV vIL-6, in HIV-seronegative Castleman's disease. Am J Pathol 1997, 151(6):1517-1522.
67. Coscoy L, Ganem D: A viral protein that selectively downregulates ICAM-1 and B7-2 and modulates T cell costimulation. J Clin Invest 2001, 107(12):1599-1606.
68. Belanger C, Gravel A, Tomoiu A, Janelle ME, Gosselin J, Tremblay MJ, Flamand L: Human herpesvirus 8 viral FLICE-inhibitory protein inhibits Fas-mediated apoptosis through binding and prevention of procaspase-8 maturation. J Hum Virol 2001, 4(2):62-73.
69. Murphy PM: Viral exploitation and subversion of the immune system through chemokine mimicry. Nature Immunology 2001, 2(2):116-122.
70. Moore PS, Chang Y: Kaposi's sarcoma-associated herpesvirus immunoevasion and tumorigenesis: two sides of the same coin? Annual Review of Microbiology 2003, 57:609-639.
71. Boshoff C, Endo Y, Collins PD, Takeuchi Y, Reeves JD, Schweickart VL, Siani MA, Sasaki T, Williams TJ, Gray PW, et al.: Angiogenic and HIV-inhibitory functions of KSHV-encoded chemokines. Science 1997, 278(5336):290-294.
72. Stine JT, Wood C, Hill M, Epp A, Raport CJ, Schweickart VL, Endo Y, Sasaki T, Simmons G, Boshoff C, et al.: KSHV-encoded CC chemokine vMIP-III is a CCR4 agonist, stimulates angiogenesis, and selectively chemoattracts TH2 cells. Blood 2000, 95(4):1151-1157.
73. Chung YH, Means RE, Choi JK, Lee BS, Jung JU: Kaposi's sarcoma-associated herpesvirus OX2 glycoprotein activates myeloid-lineage cells to induce inflammatory cytokine production. J Virol 2002, 76(10):4688-4698.
74. Martin JN, Ganem DE, Osmond DH, Page-Shafer KA, Macrae D, Kedes DH: Sexual transmission and the natural history of human herpesvirus 8 infection. N Engl J Med 1998, 338(14):948-954.
75. Lampinen TM, Kulasingam S, Min J, Borok M, Gwanzura L, Lamb J, Mahomed K, Woelk GB, Strand KB, Bosch ML, et al.: Detection of Kaposi's sarcoma-associated herpesvirus in oral and genital secretions of Zimbabwean women. J Infect Dis 2000, 181(5):1785-1790.
76. Cannon MJ, Dollard SC, Smith DK, Klein RS, Schuman P, Rich JD, Vlahov D, Pellett PE, Group HIVERS: Blood-borne and sexual transmission of human herpesvirus 8 in women with or at risk for human immunodeficiency virus infection. N Engl J Med 2001, 344(9):637-643.
77. Lefrere JJ, Mariotti M, Girot R, Loiseau P, Herve P: Transfusional risk of HHV-8 infection [letter; comment]. Lancet 1997, 350(9072):217.
78. Engels EA, Eastman H, Ablashi DV, Wilks RJ, Braham J, Manns A: Risk of transfusion-associated transmission of human herpesvirus 8. J Natl Cancer Inst 1999, 91(20):1773-1775.
79. Pellett PE, Wright DJ, Engels EA, Ablashi DV, Dollard SC, Forghani B, Glynn SA, Goedert JJ, Jenkins FJ, Lee TH, et al.: Multicenter comparison of serologic assays and estimation of human herpesvirus 8 seroprevalence among US blood donors. Transfusion 2003, 43(9):1260-1268.
80. Goedert JJ, Charurat M, Blattner WA, Hershow RC, Pitt J, Diaz C, Mofenson LM, Green K, Minkoff H, Paul ME, et al.: Risk factors for Kaposi's sarcoma-associated herpesvirus infection among HIV-1-infected pregnant women in the USA. Aids 2003, 17(3):425-433.
81. Davidovici B, Karakis I, Bourboulia D, Ariad S, Zong J, Benharroch D, Dupin N, Weiss R, Hayward G, Sarov B, et al.: Seroepidemiology and molecular epidemiology of Kaposi's sarcoma-associated herpesvirus among Jewish population groups in Israel. J Natl Cancer Inst 2001, 93(3):194-202.
82. Plancoulaine S, Abel L, van Beveren M, Tregouet DA, Joubert M, Tortevoye P, de The G, Gessain A: Human herpesvirus 8 transmission from mother to child and between siblings in an endemic population. Lancet 2000, 356(9235):1062-1065.
83. Gessain A, Mauclere P, van Beveren M, Plancoulaine S, Ayouba A, Essame-Oyono JL, Martin PM, de The G: Human herpesvirus 8 primary infection occurs during childhood in Cameroon, Central Africa. Int J Cancer 1999, 81(2):189-192.
84. Brayfield BP, Phiri S, Kankasa C, Muyanga J, Mantina H, Kwenda G, West JT, Bhat G, Marx DB, Klaskala W, et al.: Postnatal human herpesvirus 8 and human immunodeficiency virus type 1 infection in mothers and infants from Zambia. Journal of Infectious Diseases 2003, 187(4):559-568.
85. Brayfield BP, Kankasa C, West JT, Muyanga J, Bhat G, Klaskala W, Mitchell CD, Wood C: Distribution of Kaposi sarcoma-associated herpesvirus/human herpesvirus 8 in maternal saliva and breast milk in Zambia: implications for transmission. Journal of Infectious Diseases 2004, 189(12):2260-2270.
86. Dedicoat M, Newton R, Alkharsah KR, Sheldon J, Szabados I, Ndlovu B, Page T, Casabonne D, Gilks CF, Cassol SA, et al.: Mother-to-child transmission of human herpesvirus-8 in South Africa. Journal of Infectious Diseases 2004, 190(6):1068-1075.
87. Coluzzi M, Calabro ML, Manno D, Chieco-Bianchi L, Schulz TF, Ascoli V: Reduced seroprevalence of Kaposi's sarcoma-associated herpesvirus (KSHV), human herpesvirus 8 (HHV8), related to suppression of Anopheles density in Italy. Medical & Veterinary Entomology 2003, 17(4):461-464.
88. Ho M, Suwansirikul S, Dowling JN, Youngblood LA, Armstrong JA: The transplanted kidney as a source of cytomegalovirus infection. New England Journal of Medicine 1975, 293(22):1109-1112.
89. Penn I: Kaposi's sarcoma in transplant recipients. Transplantation 1997, 64(5):669-673.
90. Parravicini C, Olsen SJ, Capra M, Poli F, Sirchia G, Gao SJ, Berti E, Nocera A, Rossi E, Bestetti G, et al.: Risk of Kaposi's sarcoma-associated herpes virus transmission from donor allografts among Italian posttransplant Kaposi's sarcoma patients. Blood 1997, 90(7):2826-2829.
91. Rady PL, Yen A, Rollefson JL, Orengo I, Bruce S, Hughes TK, Tyring SK: Herpesvirus-like DNA sequences in non-Kaposi's sarcoma skin lesions of transplant patients. Lancet 1995, 345(8961):1339-1340.
92. Regamey N, Tamm M, Wernli M, Witschi A, Thiel G, Cathomas G, Erb P: Transmission of human herpesvirus 8 infection from renal-transplant donors to recipients. N Engl J Med 1998, 339(19):1358-1363.
93. Luppi M, Barozzi P, Santagostino G, Trovato R, Schulz TF, Marasca R, Bottalico D, Bignardi L, Torelli G: Molecular evidence of organ-related transmission of Kaposi sarcoma-associated herpesvirus or human herpesvirus-8 in transplant patients. Blood 2000, 96(9):3279-3281.
94. Sarid R, Pizov G, Rubinger D, Backenroth R, Friedlaender MM, Schwartz F, Wolf DG: Detection of human herpesvirus-8 DNA in kidney allografts prior to the development of Kaposi's sarcoma. Clin Infect Dis 2001, 32(10):1502-1505.
95. Munoz P, Alvarez P, de Ory F, Pozo F, Rivera M, Bouza E: Incidence and clinical characteristics of Kaposi sarcoma after solid organ transplantation in Spain: importance of seroconversion against HHV-8. Medicine 2002, 81(4):293-304.
96. Jenkins FJ, Hoffman LJ, Liegey-Dougall A: Reactivation of and primary infection with human herpesvirus 8 among solid-organ transplant recipients. Journal of Infectious Diseases 2002, 185(9):1238-1243.
97. Andreoni M, Goletti D, Pezzotti P, Pozzetto A, Monini P, Sarmati L, Farchi F, Tisone G, Piazza A, Pisani F, et al.: Prevalence, incidence and correlates of HHV-8/KSHV infection and Kaposi's sarcoma in renal and liver transplant recipients. J Infect 2001, 43(3):195-199.
98. Hudnall SD, Rady PL, Tyring SK, Fish JC: Serologic and molecular evidence of human herpesvirus 8 activation in renal transplant recipients. J Infect Dis 1998, 178(6):1791-1794.
99. Gray JJ: Avidity of EBV VCA-specific IgG antibodies: distinction between recent primary infection, past infection and reactivation. Journal of Virological Methods 1995, 52(1-2):95-104.
100. Barozzi P, Luppi M, Facchetti F, Mecucci C, Alu M, Sarid R, Rasini V, Ravazzini L, Rossi E, Festa S, et al.: Post-transplant Kaposi sarcoma originates from the seeding of donor-derived progenitors comment erratum appears in Nat Med 2003 Jul;9(7):975. Nature Medicine 2003, 9(5):554-561.
101. Moosa MR, Treurnicht FK, van Rensburg EJ, Schneider JW, Jordaan HF, Engelbrecht S: Detection and subtyping of human herpesvirus-8 in renal transplant patients before and after remission of Kaposi's sarcoma. Transplantation 1998, 66(2):214-218.
102. Browning PJ, Sechler JM, Kaplan M, Washington RH, Gendelman R, Yarchoan R, Ensoli B, Gallo RC: Identification and culture of Kaposi's sarcoma-like spindle cells from the peripheral blood of human immunodeficiency virus-1-infected individuals and normal controls. Blood 1994, 84(8):2711-2720.
103. Kapelushnik J, Ariad S, Benharroch D, Landau D, Moser A, Delsol G, Brousset P: Post renal transplantation human herpesvirus 8-associated lymphoproliferative disorder and Kaposi's sarcoma. Br J Haematol 2001, 113(2):425-428.
104. Luppi M, Barozzi P, Schulz TF, Setti G, Staskus K, Trovato R, Narni F, Donelli A, Maiorana A, Marasca R, et al.: Bone marrow failure associated with human herpesvirus 8 infection after transplantation. N Engl J Med 2000, 343(19):1378-1385.
105. Kaposi M: Idiopathic multiple pigmented sarcoma of the skin. Archiv fur Dermatologie und Syphilis 1872, 4:265-273.
106. Antman K, Chang Y: Kaposi's sarcoma. N Engl J Med 2000, 342(14):1027-1038.
107. Ablashi DV, Chatlynne LG, Whitman JE, Cesarman E: Spectrum of Kaposi's sarcoma-associated herpesvirus, or human herpesvirus 8, diseases. Clinical Microbiology Reviews 2002, 15(3):439-464.
108. Fredericks DN, Relman DA: Sequence-based identification of microbial pathogens: a reconsideration of Koch's postulates. Clin Microbiol Rev 1996, 9(1):18-33.
109. Hill AB: The environment and disease: Association or causation? Proceedings of the Royal Society of Medicine 1965, 58:295-300.
110. Tappero JW, Conant MA, Wolfe SF, Berger TG: Kaposi's sarcoma. Epidemiology, pathogenesis, histology, clinical spectrum, staging criteria and therapy. J Am Acad Dermatol 1993, 28(3):371-395.
111. Buonaguro FM, Tornesello ML, Beth-Giraldo E, Hatzakis A, Mueller N, Downing R, Biryamwaho B, Sempala SD, Giraldo G: Herpesvirus-like DNA sequences detected in endemic, classic, iatrogenic and epidemic Kaposi's sarcoma (KS) biopsies. Int J Cancer 1996, 65(1):25-28.
112. Chatlynne LG, Ablashi DV: Seroepidemiology of Kaposi's sarcoma-associated herpesvirus (KSHV). Semin Cancer Biol 1999, 9(3):175-185.
113. Davis DA, Humphrey RW, Newcomb FM, O'Brien TR, Goedert JJ, Straus SE, Yarchoan R: Detection of serum antibodies to a Kaposi's sarcoma-associated herpesvirus-specific peptide. J Infect Dis 1997, 175(5):1071-1079.
114. Gao SJ, Kingsley L, Hoover DR, Spira TJ, Rinaldo CR, Saah A, Phair J, Detels R, Parry P, Chang Y, et al.: Seroconversion to antibodies against Kaposi's sarcoma-associated herpesvirus-related latent nuclear antigens before the development of Kaposi's sarcoma. N Engl J Med 1996, 335(4):233-241.
115. Flore O, Rafii S, Ely S, O'Leary JJ, Hyjek EM, Cesarman E: Transformation of primary human endothelial cells by Kaposi's sarcoma-associated herpesvirus. Nature 1998, 394(6693):588-592.
116. Iscovich J, Boffetta P, Franceschi S, Azizi E, Sarid R: Classic kaposi sarcoma: epidemiology and risk factors. Cancer 2000, 88(3):500-517.
117. Hengge UR, Ruzicka T, Tyring SK, Stuschke M, Roggendorf M, Schwartz RA, Seeber S: Update on Kaposi's sarcoma and other HHV8 associated diseases Part 1: epidemiology, environmental predispositions, clinical manifestations, and therapy. The Lancet Infectious Diseases 2002, 2(5):281-292.
118. Brenner B, Weissmann-Brenner A, Rakowsky E, Weltfriend S, Fenig E, Friedman-Birnbaum R, Sulkes A, Linn S: Classical Kaposi sarcoma: prognostic factor analysis of 248 patients. Cancer 2002, 95(9):1982-1987.
119. Goedert JJ, Vitale F, Lauria C, Serraino D, Tamburini M, Montella M, Messina A, Brown EE, Rezza G, Gafa L, et al.: Risk factors for classical Kaposi's sarcoma. Journal of the National Cancer Institute 2002, 94(22):1712-1718.
120. Goedert JJ: The epidemiology of acquired immunodeficiency syndrome malignancies. Semin Oncol 2000, 27(4):390-401.
121. Schwartz RA: Kaposi's sarcoma: advances and perspectives. J Am Acad Dermatol 1996, 34(5 Pt 1):804-814.
122. Jacobson LP, Jenkins FJ, Springer G, Munoz A, Shah KV, Phair J, Zhang Z, Armenian H: Interaction of human immunodeficiency virus type 1 and human herpesvirus type 8 infections on the incidence of Kaposi's sarcoma. J Infect Dis 2000, 181(6):1940-1949.
123. Renwick N, Halaby T, Weverling GJ, Dukers NH, Simpson GR, Coutinho RA, Lange JM, Schulz TF, Goudsmit J: Seroconversion for human herpesvirus 8 during HIV infection is highly predictive of Kaposi's sarcoma. AIDS 1998, 12(18):2481-2488.
124. Grossman Z, Iscovich J, Schwartz F, Azizi E, Klepfish A, Schattner A, Sarid R: Absence of Kaposi sarcoma among Ethiopian immigrants to Israel despite high seroprevalence of human herpesvirus 8. Mayo Clinic Proceedings 2002, 77(9):905-909.
125. Dourmishev LA, Dourmishev AL, Palmeri D, Schwartz RA, Lukac DM: Molecular genetics of Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8) epidemiology and pathogenesis. Microbiology & Molecular Biology Reviews 2003, 67(2):175-212. table of contents.
126. Wabinga HR, Parkin DM, Wabwire-Mangen F, Mugerwa JW: Cancer in Kampala, Uganda, in 1989-91: changes in incidence in the era of AIDS. International Journal of Cancer 1993, 54(1):26-36.
127. Chang Y, Ziegler J, Wabinga H, Katangole-Mbidde E, Boshoff C, Schulz T, Whitby D, Maddalena D, Jaffe HW, Weiss RA, et al.: Kaposi's sarcoma-associated herpesvirus and Kaposi's sarcoma in Africa. Uganda Kaposi's Sarcoma Study Group. Arch Intern Med 1996, 156(2):202-204.
128. Mayama S, Cuevas LE, Sheldon J, Omar OH, Smith DH, Okong P, Silvel B, Hart CA, Schulz TF: Prevalence and transmission of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in Ugandan children and adolescents. Int J Cancer 1998, 77(6):817-820.
129. Ariyoshi K, Schim van der Loeff M, Cook P, Whitby D, Corrah T, Jaffar S, Cham F, Sabally S, O'Donovan D, Weiss RA, et al.: Kaposi's sarcoma in the Gambia, West Africa is less frequent in human immunodeficiency virus type 2 than in human immunodeficiency virus type 1 infection despite a high prevalence of human herpesvirus 8. J Hum Virol 1998, 1(3):193-199.
130. Hudnall SD, Rady PL, Tyring SK, Fish JC: Hydrocortisone activation of human herpesvirus 8 viral DNA replication and gene expression in vitro. Transplantation 1999, 67(5):648-652.
131. Nador RG, Cesarman E, Chadburn A, Dawson DB, Ansari MQ, Sald J, Knowles DM: Primary effusion lymphoma: a distinct clinicopathologic entity associated with the Kaposi's sarcoma-associated herpes virus. Blood 1996, 88(2):645-656.
132. Arvanitakis L, Mesri EA, Nador RG, Said JW, Asch AS, Knowles DM, Cesarman E: Establishment and characterization of a primary effusion (body cavity-based) lymphoma cell line (BC-3) harboring kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) in the absence of Epstein-Barr virus. Blood 1996, 88(7):2648-2654.
133. Boshoff C, Gao SJ, Healy LE, Matthews S, Thomas AJ, Coignet L, Warnke RA, Strauchen JA, Matutes E, Kamel OW, et al.: Establishing a KSHV+ cell line (BCP-1) from peripheral blood and characterizing its growth in Nod/SCID mice. Blood 1998, 91(5):1671-1679.
134. Cesarman E, Moore PS, Rao PH, Inghirami G, Knowles DM, Chang Y: In vitro establishment and characterization of two acquired immunodeficiency syndrome-related lymphoma cell lines (BC-1 and BC-2) containing Kaposi's sarcoma-associated herpesvirus-like (KSHV) DNA sequences. Blood 1995, 86(7):2708-2714.
135. Drexler HG, Uphoff CC, Gaidano G, Carbone A: Lymphoma cell lines: in vitro models for the study of HHV-8+ primary effusion lymphomas (body cavity-based lymphomas). Leukemia 1998, 12(10):1507-1517.
136. Gaidano G, Cechova K, Chang Y, Moore PS, Knowles DM, Dalla-Favera R: Establishment of AIDS-related lymphoma cell lines from lymphomatous effusions. Leukemia 1996, 10(7):1237-1240.
137. Mbulaiteye SM, Biggar RJ, Goedert JJ, Engels EA: Pleural and peritoneal lymphoma among people with AIDS in the United States. Journal of Acquired Immune Deficiency Syndromes: JAIDS 2002, 29(4):418-421.
138. Ascoli V, Lo Coco F, Torelli G, Vallisa D, Cavanna L, Bergonzi C, Luppi M: Human herpesvirus 8-associated primary effusion lymphoma in HIV-patients: a clinicopidemiologic variant resembling classic Kaposi's sarcoma. Haematologica 2002, 87(4):339-343.
139. Soulier J, Grollet L, Oksenhendler E, Miclea JM, Cacoub P, Baruchel A, Brice P, Clauvel JP, d'Agay MF, Raphael M, et al.: Molecular analysis of clonality in Castleman's disease. Blood 1995, 86(3):1131-1138.
140. Katano H, Sato Y, Kurata T, Mori S, Sata T: Expression and localization of human herpesvirus 8-encoded proteins in primary effusion lymphoma, Kaposi's sarcoma, and multicentric Castleman's disease. Virology 2000, 269(2):335-344.
141. Soulier J, Grollet L, Oksenhendler E, Cacoub P, Cazals-Hatem D, Babinet P, d'Agay MF, Clauvel JP, Raphael M, Degos L, et al.: Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease. Blood 1995, 86(4):1276-1280.
142. Marcoval J, Mana J, Moreno A, Gallego I, Fortuno Y, Peyri J: Foreign bodies in granulomatous cutaneous lesions of patients with systemic sarcoidosis. Archives of Dermatology 2001, 137(4):427-430.
143. Di Alberti L, Piattelli A, Artese L, Favia G, Patel S, Saunders N, Porter SR, Scully CM, Ngui SL, Teo CG: Human herpesvirus 8 variants in sarcoid tissues. Lancet 1997, 350(9092):1655-1661.
144. Belec L, Mohamed AS, Lechapt-Zalcman E, Authier FJ, Lange F, Gherardi RK: Lack of HHV-8 DNA sequences in sarcoid tissues of French patients [letter]. Chest 1998, 114(3):948-949.
145. Lebbe C, Agbalika F, Flageul B, Pellet C, Rybojad M, Cordoliani F, Farge D, Vignon-Pennamen MD, Sheldon J, Morel P, et al.: No evidence for a role of human herpesvirus type 8 in sarcoidosis: molecular and serological analysis. Br J Dermatol 1999, 141(3):492-496.
146. Mendelson J, Howley P, Israel M, Liotta L: The Molecular Basis of Cancer. Philadelphia, PA: WB Saunders Company; 1995.
147. Kawano M, Hirano T, Matsuda T, Taga T, Horii Y, Iwato K, Asaoku H, Tang B, Tanabe O, Tanaka H, et al.: Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas. Nature 1988, 332(6159):83-85.
148. Lichtenstein A, Berenson J, Norman D, Chang MP, Carlile A: Production of cytokines by bone marrow cells obtained from patients with multiple myeloma. Blood 1989, 74(4):1266-1273.
149. Rettig MB, Ma HJ, Vescio RA, Pold M, Schiller G, Belson D, Savage A, Nishikubo C, Wu C, Fraser J, et al.: Kaposi's sarcoma-associated herpesvirus infection of bone marrow dendritic cells from multiple myeloma patients. Science 1997, 276(5320):1851-1854.
150. Said JW, Rettig MR, Heppner K, Vescio RA, Schiller G, Ma HJ, Belson D, Savage A, Shintaku IP, Koeffler HP, et al.: Localization of Kaposi's sarcoma-associated herpesvirus in bone marrow biopsy samples from patients with multiple myeloma. Blood 1997, 90(11):4278-4282.
151. Gao SJ, Alsina M, Deng JH, Harrison CR, Montalvo EA, Leach CT, Roodman GD, Jenson HB: Antibodies to Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in patients with multiple myeloma. J Infect Dis 1998, 178(3):846-849.
152. Whitby D, Boshoff C, Luppi M, Torelli G: Kaposi's sarcoma-associated herpesvirus infection and multiple myeloma [letter; comment]. Science 1997, 278(5345):1971-1972. discussion 1972-1973.
153. MacKenzie J, Sheldon J, Morgan G, Cook G, Schulz TF, Jarrett RF: HHV-8 and multiple myeloma in the UK [letter]. Lancet 1997, 350(9085):1144-1145.
154. Parravicini C, Lauri E, Baldini L, Neri A, Poli F, Sirchia G, Moroni M, Galli M, Corbellino M: Kaposi's sarcoma-associated herpesvirus infection and multiple myeloma [letter; comment]. Science 1997, 278(5345):1969-1970.
155. Masood R, Zheng T, Tupule A, Arora N, Chatlynne L, Handy M, Whitman J Jr: Kaposi's sarcoma-associated herpesvirus infection and multiple myeloma [letter; comment]. Science 1997, 278(5345):1970-1971.
156. Carletti F, Mandolini C, Rossi A, Capobianchi MR, Borgia MC: Prevalence of human herpesvirus (HHV)-8 infection among carriers of cardiovascular disease. Journal of Biological Regulators & Homeostatic Agents 2002, 16(2):110-113.
157. Memar OM, Rady PL, Goldblum RM, Yen A, Tyring SK: Human herpesvirus 8 DNA sequences in blistering skin from patients with pemphigus. Arch Dermatol 1997, 133(10):1247-1251.
158. Du MQ, Diss TC, Liu H, Ye H, Hamoudi RA, Cabecadas J, Dong HY, Harris NL, Chan JK, Rees JW, et al.: KSHV- and EBV-associated germinotropic lymphoproliferative disorder. Blood 2002, 100(9):3415-3418.
159. Gomez-Brouchet A, Delisle MB, Vital A, Brousset P: Immunohistochemical assessment of human herpesvirus 8 infection in primary central nervous system large B cell lymphomas. J Clin Pathol 2001, 54(8):617-618.
160. Kedes DH, Ganem D: Sensitivity of Kaposi's sarcoma-associated herpesvirus replication to antiviral drugs. Implications for potential therapy. J Clin Invest 1997, 99(9):2082-2086.
161. Simonart T, Noel JC, De Dobbeleer G, Parent D, Van Vooren JP, De Clercq E, Snoeck R: Treatment of classical Kaposi's sarcoma with intralesional injections of cidofovir: report of a case. J Med Virol 1998, 55(3):215-218.
162. Guillot B, Carles MJ, Foulongne V, Dereure O, Ramuz M: Lack of modification of virological status after chemotherapy or radiotherapy for classic Kaposi's sarcoma. Br J Dermatol 2002, 146(2):337-338.
163. Jones JL, Hanson DL, Dworkin MS, Jaffe HW: Incidence and trends in Kaposi's sarcoma in the era of effective antiretroviral therapy. J Acquir Immune Defic Syndr 2000, 24(3):270-274.
164. Tam HK, Zhang ZF, Jacobson LP, Margolick JB, Chmiel JS, Rinaldo C, Detels R: Effect of highly active antiretroviral therapy on survival among HIV-infected men with Kaposi sarcoma or non-Hodgkin lymphoma. Int J Cancer 2002, 98(6):916-922.
165. Paparizos VA, Kyriakis KP, Papastamopoulos V, Hadjivassiliou M, Stavrianeas NG: Response of AIDS-associated Kaposi sarcoma to highly active antiretroviral therapy alone. JAIDS Journal of Acquired Immune Deficiency Syndromes 2002, 30(2):257-258.
166. Rooney CM, Smith CA, Ng CY, Loftin S, Li C, Krance RA, Brenner MK, Heslop HE: Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation. Lancet 1995, 345(8941):9-13.
167. Gao SJ, Kingsley L, Li M, Zheng W, Parravicini C, Ziegler J, Newton R, Rinaldo CR, Saah A, Phair J, et al.: KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma. Nat Med 1996, 2(8):925-928.
168. Baillargeon J, Deng J, Hettler E, Harrison C, Grady JJ, Korte LG, Alexander J, Montalvo E, Jenson HB, Gao S: Seroprevalence of Kaposi's Sarcoma-Associated Herpesvirus Infection among Blood Donors from Texas. Ann Epidemiol 2001, 11(7):512-518.
169. Atkinson J, Edlin BR, Engels EA, Kral AH, Seal K, Gamache CJ, Whitby D, O'Brien TR: Seroprevalence of human herpesvirus 8 among injection drug users in San Francisco. Journal of Infectious Diseases 2003, 187(6):974-981.
170. O'Brien TR, Kedes D, Ganem D, Macrae DR, Rosenberg PS, Molden J, Goedert JJ: Evidence for concurrent epidemics of human herpesvirus 8 and human immunodeficiency virus type 1 in US homosexual men: rates, risk factors, and relationship to Kaposi's sarcoma. J Infect Dis 1999, 180(4):1010-1017.
171. Engels EA, Clark E, Aledort LM, Goedert JJ, Whitby D: Kaposi's sarcoma-associated herpesvirus infection in elderly Jews and non-Jews from New York City. International Journal of Epidemiology 2002, 31(5):946-950.
172. Baillargeon J, Leach CT, Deng JH, Gao SJ, Jenson HB: High prevalence of human herpesvirus 8 (HHV-8) infection in south Texas children. Journal of Medical Virology 2002, 67(4):542-548.
173. Delorme S, Houde I, Deschenes L: Seroprevalence of antibodies against human herpesvirus 8 in a population of renal transplant recipients at Hotel-Dieu de Quebec Hospital. Journal of Clinical Microbiology 2003, 41(11):5207-5208.
174. Manns A, Strickler HD, Hanchard B, Manassaram DM, Waters D, Ablashi DV: Age- and sex-specific seroprevalence of human herpesvirus 8 in Jamaica [letter; comment]. J Natl Cancer Inst 1998, 90(14):1102-1104.
175. Kouri V, Eng SM, Rodriguez ME, Resik S, Orraca O, Moore PS, Chang Y: Seroprevalence of Kaposi's sarcoma-associated herpesvirus in various populations in Cuba. Pan American Journal of Public Health 2004, 15(5):320-325.
176. Sosa C, Klaskala W, Chandran B, Soto R, Sieczkowski L, Wu MH, Baum M, Wood C: Human herpesvirus 8 as a potential sexually transmitted agent in Honduras. J Infect Dis 1998, 178(2):547-551.
177. Biggar RJ, Whitby D, Marshall V, Linhares AC, Black F: Human herpesvirus 8 in Brazilian Amerindians: a hyperendemic population with a new subtype. J Infect Dis 2000, 181(5):1562-1568.
178. Freitas RB, Freitas MR, Linhares AC: Prevalence of human herpesvirus 8 antibodies in the population of Belem, Para, Brazil. Revista do Instituto de Medicina Tropical de Sao Paulo 2002, 44(6):309-313.
179. Whitby D, Marshall VA, Bagni RK, Wang CD, Gamache CJ, Guzman JR, Kron M, Ebbesen P, Biggar RJ: Genotypic characterization of Kaposi's sarcoma-associated herpesvirus in asymptomatic infected subjects from isolated populations. Journal of General Virology 2004, 85(Pt 1):155-163.
180. Perez C, Tous M, Gallego S, Zala N, Rabinovich O, Garbiero S, Martinez MJ, Cunha AM, Camino S, Camara A, et al.: Seroprevalence of human herpesvirus-8 in blood donors from different geographical regions of Argentina, Brazil, and Chile. Journal of Medical Virology 2004, 72(4):661-667.
181. Sosa C, Benetucci J, Hanna C, Sieczkowski L, Deluchi G, Canizal AM, Mantina H, Klaskala W, Baum M, Wood C: Human herpesvirus 8 can be transmitted through blood in drug addicts. Medicina (Mex) 2001, 61(3):291-294.
182. Keller R, Zago A, Viana MC, Bourboulia D, Desgranges C, Casseb J, Moura WV, Dietze R, Collandre H: HHV-8 infection in patients with AIDS-related Kaposi's sarcoma in Brazil. Brazilian Journal of Medical & Biological Research 2001, 34(7):879-886.
183. Juhasz A, Remenyik E, Konya J, Veress G, Begany A, Andirko I, Medgyessy I, Hunyadi J, Gergely L: Prevalence and age distribution of human herpesvirus-8 specific antibodies in Hungarian blood donors. J Med Virol 2001, 64(4):526-530.
184. Regamey N, Cathomas G, Schwager M, Wernli M, Harr T, Erb P: High human herpesvirus 8 seroprevalence in the homosexual population in Switzerland. J Clin Microbiol 1998, 36(6):1784-1786.
185. Gambus G, Bourboulia D, Esteve A, Lahoz R, Rodriguez C, Bolao F, Sirera G, Muga R, del Romero J, Boshoff C, et al.: Prevalence and distribution of HHV-8 in different subpopulations, with and without HIV infection, in Spain. AIDS 2001, 15(9):1167-1174.
186. Preiser W, Szep NI, Lang D, Doerr HW, Rabenau HF: Kaposi's sarcoma-associated herpesvirus seroprevalence in selected german patients: evaluation by different test systems. Medical Microbiology & Immunology 2001, 190(3):121-127.
187. Graffeo R, Ranno S, Marchetti S, Capodicasa N, Schito AM, Fuga L, Amico R, Cattani P, Fadda G: HHV 8 seroprevalence and transmission within Albanian family groups. New Microbiologica 2003, 26(1):1-6.
188. Janier M, Agbalika F, de La Salmoniere P, Lassau F, Lagrange P, Morel P: Human herpesvirus 8 seroprevalence in an STD clinic in Paris: a study of 512 patients. Sexually Transmitted Diseases 2002, 29(11):698-702.
189. Whitby D, Luppi M, Barozzi P, Boshoff C, Weiss RA, Torelli G: Human herpesvirus 8 seroprevalence in blood donors and lymphoma patients from different regions of Italy. J Natl Cancer Inst 1998, 90(5):395-397.
190. Rezza G, Lennette ET, Giuliani M, Pezzotti P, Caprilli F, Monini P, Butto S, Lodi G, Di Carlo A, Levy JA, et al.: Prevalence and determinants of anti-lytic and anti-latent antibodies to human herpesvirus-8 among Italian individuals at risk of sexually and parenterally transmitted infections. Int J Cancer 1998, 77(3):361-365.
191. Andreoni M, El-Sawaf G, Rezza G, Ensoli B, Nicastri E, Ventura L, Ercoli L, Sarmati L, Rocchi G: High seroprevalence of antibodies to human herpesvirus-8 in Egyptian children: evidence of nonsexual transmission. J Natl Cancer Inst 1999, 91(5):465-469.
192. Calabro ML, Sheldon J, Favero A, Simpson GR, Fiore JR, Gomes E, Angarano G, Chieco-Bianchi L, Schulz TF: Seroprevalence of Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 in several regions of Italy. J Hum Virol 1998, 1(3):207-213.
193. Perna AM, Bonura F, Vitale F, Viviano E, Di Benedetto MA, Ajello F, Villafrate MR, Prestileo T, Mancuso S, Goedert JJ, et al.: Antibodies to human herpes virus type 8 (HHV8) in general population and in individuals at risk for sexually transmitted diseases in Western Sicily. Int J Epidemiol 2000, 29(1):175-179.
194. Engels EA, Sinclair MD, Biggar RJ, Whitby D, Ebbesen P, Goedert JJ, Gastwirth JL: Latent class analysis of human herpesvirus 8 assay performance and infection prevalence in sub-saharan Africa and Malta. Int J Cancer 2000, 88(6):1003-1008.
195. Iscovich J, Fischbein A, Fisher-Fischbein J, Freedman LS, Eng SM, Boffetta P, Vudovich A, Glasman C, Goldschmidt R, Livingston M, et al.: Seroprevalence of Kaposi's sarcoma-associated herpesvirus in healthy adults in Israel. Anticancer Res 2000, 20(3B):2119-2122.
196. Huang LM, Huang SY, Chen M, Chao M, Lu CY, Tien HF, Lee CY, Jeang KT: Geographical differences in human herpesvirus 8 seroepidemiology: a survey of 1,201 individuals in Asia. J Med Virol 2000, 60(3):290-293.
197. Wang YF, Lee SB, Cheng LC, Tai MH, Su IJ: Detection of serum antibodies to three different recombinant antigens of human herpesvirus 8 by immunoblotting: seroprevalence studies in Taiwan. Clinica Chimica Acta 2002, 320(1-2):37-42.
198. Dilnur P, Katano H, Wang ZH, Osakabe Y, Kudo M, Sata T, Ebihara Y: Classic type of Kaposi's sarcoma and human herpesvirus 8 infection in Xinjiang, China. Pathol Int 2001, 51(11):845-852.
199. Ayuthaya PI, Katano H, Inagi R, Auwanit W, Sata T, Kurata T, Yamanishi K: The seroprevalence of human herpesvirus 8 infection in the Thai population. Southeast Asian Journal of Tropical Medicine & Public Health 2002, 33(2):297-305.
200. Fujii T, Taguchi H, Katano H, Mori S, Nakamura T, Nojiri N, Nakajima K, Tadokoro K, Juji T, Iwamoto A: Seroprevalence of human herpesvirus 8 in human immunodeficiency virus 1-positive and human immunodeficiency virus 1-negative populations in Japan. J Med Virol 1999, 57(2):159-162.
201. Rezza G, Danaya RT, Wagner TM, Sarmati L, Owen IL, Monini P, Andreoni M, Suligoi B, Ensoli B, Pozio E: Human herpesvirus-8 and other viral infections, Papua New Guinea. Emerging Infectious Diseases 2001, 7(5):893-895.
202. He J, Bhat G, Kankasa C, Chintu C, Mitchell C, Duan W, Wood C: Seroprevalence of human herpesvirus 8 among Zambian women of childbearing age without Kaposi's sarcoma (KS) and mother-child pairs with KS. J Infect Dis 1998, 178(6):1787-1790.
203. Sitas F, Carrara H, Beral V, Newton R, Reeves G, Bull D, Jentsch U, Pacella-Norman R, Bourboulia D, Whitby D, et al.: Antibodies against human herpesvirus 8 in black South African patients with cancer. N Engl J Med 1999, 340(24):1863-1871.
204. Constantine NT, Fox E, Abbatte EA, Woody JN: Diagnostic usefulness of five screening assays for HIV in an east African city where prevalence of infection is low. AIDS 1989, 3(5):313-317.
205. Callahan JD, Constantine NT, Kataaha P, Zhang X, Hyams KC, Bansal J: Second generation hepatitis C virus assays: performance when testing African sera. J Med Virol 1993, 41(1):35-38.
206. Hayward GS: KSHV strains: the origins and global spread of the virus. Semin Cancer Biol 1999, 9(3):187-199.
207. Lee H, Guo J, Li M, Choi JK, DeMaria M, Rosenzweig M, Jung JU: Identification of an immunoreceptor tyrosine-based activation motif of K1 transforming protein of Kaposi's sarcoma-associated herpesvirus. Molecular & Cellular Biology 1998, 18(9):5219-5228.
208. Kasolo FC, Monze M, Obel N, Anderson RA, French C, Gompels UA: Sequence analyses of human herpesvirus-8 strains from both African human immunodeficiency virus-negative and -positive childhood endemic Kaposi's sarcoma show a close relationship with strains identified in febrile children and high variation in the K1 glycoprotein. J Gen Virol 1998, 79(Pt 12):3055-3065.
209. Kedes DH, Lagunoff M, Renne R, Ganem D: Identification of the gene encoding the major latency-associated nuclear antigen of the Kaposi's sarcoma-associated herpesvirus. J Clin Invest 1997, 100(10):2606-2610.
210. Kellam P, Boshoff C, Whitby D, Matthews S, Weiss RA, Talbot SJ: Identification of a major latent nuclear antigen, LNA-1, in the human herpesvirus 8 genome. J Hum Virol 1997, 1(1):19-29.
211. Rainbow L, Platt GM, Simpson GR, Sarid R, Gao SJ, Stoiber H, Herrington CS, Moore PS, Schulz TF: The 222- to 234-kilodalton latent nuclear protein (LNA) of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) is encoded by orf73 and is a component of the latency-associated nuclear antigen. J Virol 1997, 71(8):5915-5921.
212. Katano H, Sato Y, Kurata T, Mori S, Sata T: High expression of HHV-8-encoded ORF73 protein in spindle-shaped cells of Kaposi's sarcoma. Am J Pathol 1999, 155(1):47-52.
213. Dupin N, Fisher C, Kellam P, Ariad S, Tulliez M, Franck N, van Marck E, Salmon D, Gorin I, Escande JP, et al.: Distribution of human herpesvirus-8 latently infected cells in Kaposi's sarcoma, multicentric Castleman's disease, and primary effusion lymphoma. Proc Natl Acad Sci U S A 1999, 96(8):4546-4551.
214. Edelman DC, Ketema F, Saville RD, Herman J, Sill AM, Gill PS, Blattner WA, Constantine NT: Specifics on the refinement and application of two serological assays for the detection of antibodies to HHV-8. J Clin Virol 2000, 16(3):225-237.
215. Lin SF, Sun R, Heston L, Gradoville L, Shedd D, Haglund K, Rigsby M, Miller G: Identification, expression, and immunogenicity of Kaposi's sarcoma-associated herpesvirus-encoded small viral capsid antigen. J Virol 1997, 71(4):3069-3076.
216. Pau CP, Lam LL, Spira TJ, Black JB, Stewart JA, Pellett PE, Respess RA: Mapping and serodiagnostic application of a dominant epitope within the human herpesvirus 8 ORF 65-encoded protein. J Clin Microbiol 1998, 36(6):1574-1577.
217. Nealon K, Newcomb WW, Pray TR, Craik CS, Brown JC, Kedes DH: Lytic replication of Kaposi's sarcoma-associated herpesvirus results in the formation of multiple capsid species: isolation and molecular characterization of A, B, and C capsids from a gammaherpesvirus. J Virol 2001, 75(6):2866-2878.
218. Lo P, Yu X, Atanasov I, Chandran B, Zhou ZH: Three-dimensional localization of pORF65 in Kaposi's sarcoma-associated herpesvirus capsid. Journal of Virology 2003, 77(7):4291-4297.
219. Chandran B, Bloomer C, Chan SR, Zhu L, Goldstein E, Horvat R: Human herpesvirus-8 ORF K8.1 gene encodes immunogenic glycoproteins generated by spliced transcripts. Virology 1998, 249(1):140-149.
220. Chandran B, Smith MS, Koelle DM, Corey L, Horvat R, Goldstein E: Reactivities of human sera with human herpesvirus-8-infected BCBL-1 cells and identification of HHV-8-specific proteins and glycoproteins and the encoding cDNAs. Virology 1998, 243(1):208-217.
221. Raab MS, Albrecht JC, Birkmann A, Yaguboglu S, Lang D, Fleckenstein B, Neipel F: The immunogenic glycoprotein gp35-37 of human herpesvirus 8 is encoded by open reading frame K8.1. J Virol 1998, 72(8):6725-6731.
222. Li M, MacKey J, Czajak SC, Desrosiers RC, Lackner AA, Jung JU: Identification and characterization of Kaposi's sarcoma-associated herpesvirus K8.1 virion glycoprotein. J Virol 1999, 73(2):1341-1349.
223. Andre S, Schatz O, Bogner JR, Zeichhardt H, Stoffler-Meilicke M, Jahn HU, Ullrich R, Sonntag AK, Kehm R, Haas J: Detection of antibodies against viral capsid proteins of human herpesvirus 8 in AIDS-associated Kaposi's sarcoma. J Mol Med 1997, 75(2):145-152.
224. Chan SR, Bloomer C, Chandran B: Identification and characterization of human herpesvirus-8 lytic cycle-associated ORF 59 protein and the encoding cDNA by monoclonal antibody. Virology 1998, 240(1):118-126.
225. Sato-Matsumura KC, Matsumura T, Nabeshima M, Katano H, Sata T, Koizumi H: Serological and immunohistochemical detection of human herpesvirus 8 in Kaposi's sarcoma after immunosuppressive therapy for bullous pemphigoid. Br J Dermatol 2001, 145(4):633-637.
226. Katano H, Sata T, Suda T, Nakamura T, Tachikawa N, Nishizumi H, Sakurada S, Hayashi Y, Koike M, Iwamoto A, et al.: Expression and antigenicity of human herpesvirus 8 encoded ORF59 protein in AIDS-associated Kaposi's sarcoma. J Med Virol 1999, 59(3):346-355.
227. Hudnall SD: Crazy 8: unraveling human herpesvirus 8 seroprevalence. Clinical Infectious Diseases 2004, 39(7):1059-1061.
228. Luka J, Kallin B, Klein G: Induction of the Epstein-Barr virus (EBV) cycle in latently infected cells by n-butyrate. Virology 1979, 94(1):228-231.
229. zur Hausen H, O'Neill FJ, Freese UK, Hecker E: Persisting oncogenic herpesvirus induced by the tumour promotor TPA. Nature 1978, 272(5651):373-375.
230. Flamand L, Zeman RA, Bryant JL, Lunardi-Iskandar Y, Gallo RC: Absence of human herpesvirus 8 DNA sequences in neoplastic Kaposi's sarcoma cell lines. JAIDS: Journal of Acquired Immune Deficiency Syndromes 1996, 13(2):194-197.
231. Chatlynne LG, Lapps W, Handy M, Huang YQ, Masood R, Hamilton AS, Said JW, Koeffler HP, Kaplan MH, Friedman-Kien A, et al.: Detection and titration of human herpesvirus-8-specific antibodies in sera from blood donors, acquired immunodeficiency syndrome patients, and Kaposi's sarcoma patients using a whole virus enzyme-linked immunosorbent assay. Blood 1998, 92(1):53-58.
232. Zhu L, Wang R, Sweat A, Goldstein E, Horvat R, Chandran B: Comparison of human sera reactivities in immunoblots with recombinant human herpesvirus (HHV)-8 proteins associated with the latent (ORF73) and lytic (ORFs 65, K8.1A, and K8.1B) replicative cycles and in immunofluorescence assays with HHV-8-infected BCBL-1 cells. Virology 1999, 256(2):381-392.
233. Wang FZ, Akula SM, Pramod NP, Zeng L, Chandran B: Human herpesvirus 8 envelope glycoprotein K8.1A interaction with the target cells involves heparan sulfate. J Virol 2001, 75(16):7517-7527.
234. Lam LL, Pau CP, Dollard SC, Pellett PE, Spira TJ: Highly sensitive assay for human herpesvirus 8 antibodies that uses a multiple antigenic peptide derived from open reading frame K8 1. J Clin Microbiol 2002, 40(2):325-329.
235. Engels EA, Whitby D, Goebel PB, Stossel A, Waters D, Pintus A, Contu L, Biggar RJ, Goedert JJ: Identifying human herpesvirus 8 infection: performance characteristics of serologic assays. J Acquir Immune Defic Syndr 2000, 23(4):346-354.
236. Sergerie Y, Abed Y, Roy J, Boivin G: Comparative evaluation of three serological methods for detection of human herpesvirus 8-specific antibodies in Canadian allogeneic stem cell transplant recipients. Journal of Clinical Microbiology 2004, 42(6):2663-2667.
237. Yu Y, Black JB, Goldsmith CS, Browning PJ, Bhalla K, Offermann MK: Induction of human herpesvirus-8 DNA replication and transcription by butyrate and TPA in BCBL-1 cells. J Gen Virol 1999, 80(Pt 1):83-90.
238. Zoeteweij JP, Eyes ST, Orenstein JM, Kawamura T, Wu L, Chandran B, Forghani B, Blauvelt A: Identification and rapid quantification of early- and late-lytic human herpesvirus 8 infection in single cells by flow cytometric analysis: characterization of anti-herpesvirus agents. J Virol 1999, 73(7):5894-5902.
239. Kedes DH, Operskalski E, Busch M, Kohn R, Flood J, Ganem D: The seroepidemiology of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus): distribution of infection in KS risk groups and evidence for sexual transmission [published erratum appears in Nat Med 1996 Sep;2(9):1041]. Nat Med 1996, 2(8):918-924.
240. Miller G, Rigsby MO, Heston L, Grogan E, Sun R, Metroka C, Levy JA, Gao SJ, Chang Y, Moore P: Antibodies to butyrate-inducible antigens of Kaposi's sarcoma-associated herpesvirus in patients with HIV-1 infection. N Engl J Med 1996, 334(20):1292-1297.
241. Baghian A, Luftig M, Black JB, Meng YX, Pau CP, Voss T, Pellett PE, Kousoulas KG: Glycoprotein B of human herpesvirus 8 is a component of the virion in a cleaved form composed of amino- and carboxyl-terminal fragments. Virology 2000, 269(1):18-25.
242. Lang D, Hinderer W, Rothe M, Sonneborn HH, Neipel F, Raab M, Rabenau H, Masquelier B, Fleury H: Comparison of the immunoglobulin-G-specific seroreactivity of different recombinant antigens of the human herpesvirus 8. Virology 1999, 260(1):47-54.
243. Olsen SJ, Tarte K, Sherman W, Hale EE, Weisse MT, Orazi A, Klein B, Chang Y: Evidence against KSHV infection in the pathogenesis of multiple myeloma. Virus Res 1998, 57(2):197-202.
244. Raje N, Kica G, Chauhan D, Zhang Y, Teoh G, Treon SP, Hideshima T, Deng JH, Gao SJ, Alsina M, et al.: Kaposi's sarcoma-associated herpesvirus gene sequences are detectable at low copy number in primary amyloidosis. Amyloid 2000, 7(2):126-132.
245. Rivas C, Thlick AE, Parravicini C, Moore PS, Chang Y: Kaposi's sarcoma-associated herpesvirus LANA2 is a B-cell-specific latent viral protein that inhibits p53. J Virol 2001, 75(1):429-438.
246. Calabro ML, Fiore JR, Favero A, Lepera A, Saracino A, Angarano G, Schulz TF, Chieco-Bianchi L: Detection of human herpesvirus 8 in cervicovaginal secretions and seroprevalence in human immunodeficiency virus type 1-seropositive and -seronegative women. J Infect Dis 1999, 179(6):1534-1537.
247. Lyall EG, Patton GS, Sheldon J, Stainsby C, Mullen J, O'Shea S, Smith NA, De Ruiter A, McClure MO, Schulz TF: Evidence for horizontal and not vertical transmission of human herpesvirus 8 in children born to human immunodeficiency virus-infected mothers. Pediatr Infect Dis J 1999, 18(9):795-799.
248. Wilkinson D, Sheldon J, Gilks CF, Schulz TF: Prevalence of infection with human herpesvirus 8/Kaposi's sarcoma herpesvirus in rural South Africa. S Afr Med J 1999, 89(5):554-557.
249. Katano H, Iwasaki T, Baba N, Terai M, Mori S, Iwamoto A, Kurata T, Sata T: Identification of antigenic proteins encoded by human herpesvirus 8 and seroprevalence in the general population and among patients with and without Kaposi's sarcoma. J Virol 2000, 74(8):3478-3485.
250. Sheldon J, Henry S, Mourad M, Bodeus M, Squifflet JP, Schulz TF, Goubau P: Human herpes virus 8 infection in kidney transplant patients in Belgium. Nephrol Dial Transplant 2000, 15(9):1443-1445.
251. Almuneef M, Nimjee S, Khoshnood K, Miller G, Rigsby MO: Prevalence of antibodies to human herpesvirus 8 (HHV-8) in Saudi Arabian patients with and without renal failure. Transplantation 2001, 71(8):1120-1124.
252. Juhasz A, Konya J, Beck Z, Remenyik E, Veress G, Begany A, Medgyessy I, Hunyadi J, Gergely L: HHV-8 ELISA based on a one-step affinity capture of biotinylated K8.1 antigen. J Virol Methods 2001, 94(1-2):163-172.
253. Caterino-De-Araujo A, de los Santos-Fortuna E, Carbone PH, Cibella SE, Moreira AA: Human herpesvirus-8 (HHV-8) antibodies in women from Sao Paulo, Brazil Association with behavioral factors and Kaposi's sarcoma. Brazilian Journal of Infectious Diseases 2003, 7(6):395-401.
254. Tedeschi R, Kvarnung M, Knekt P, Schulz TF, Szekely L, De Paoli PD, Aromaa A, Teppo L, Dillner J: A prospective seroepidemiological study of human herpesvirus-8 infection and the risk of multiple myeloma. British Journal of Cancer 2001, 84(1):122-125.
255. Spira TJ, Lam L, Dollard SC, Meng YX, Pau CP, Black JB, Burns D, Cooper B, Hamid M, Huong J, et al.: Comparison of serologic assays and PCR for diagnosis of human herpesvirus 8 infection. J Clin Microbiol 2000, 38(6):2174-2180.
256. Rabkin CS, Schulz TF, Whitby D, Lennette ET, Magpantay LI, Chatlynne L, Biggar RJ: Interassay correlation of human herpesvirus 8 serologic tests. HHV-8 Interlaboratory Collaborative Group. J Infect Dis 1998, 178(2):304-309.
257. Enbom M, Sheldon J, Lennette E, Schulz T, Ablashi DV, Neipel F, Biberfeld P, Carlberg H, Ljungman P, Nilsson A, et al.: Antibodies to human herpesvirus 8 latent and lytic antigens in blood donors and potential high-risk groups in Sweden: variable frequencies found in a multicenter serological study. J Med Virol 2000, 62(4):498-504.
258. Schatz O, Monini P, Bugarini R, Neipel F, Schulz TF, Andreoni M, Erb P, Eggers M, Haas J, Butto S, et al.: Kaposi's sarcoma-associated herpesvirus serology in Europe and Uganda: multicentre study with multiple and novel assays. J Med Virol 2001, 65(1):123-132.
259. Schulz TF: Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8): epidemiology and pathogenesis. J Antimicrob Chemother 2000, 45(Suppl T3):15-27.
260. Biggar RJ, Engels EA, Whitby D, Kedes DH, Goedert JJ: Antibody reactivity to latent and lytic antigens to human herpesvirus-8 in longitudinally followed homosexual men. Journal of Infectious Diseases 2003, 187(1):12-18.
261. Katano H, Sato Y, Sata T: Expression of p53 and human herpesvirus-8 (HHV-8)-encoded latency-associated nuclear antigen with inhibition of apoptosis in HHV-8-associated malignancies. Cancer 2001, 92(12):3076-3084.
262. Bryant-Greenwood P, Sorbara L, Filie AC, Little R, Yarchoan R, Wilson W, Raffeld M, Abati A: Infection of mesothelial cells with human herpes virus 8 in human immunodeficiency virus-infected patients with Kaposi's sarcoma, Castleman's disease, and recurrent pleural effusions. Modern Pathology 2003, 16(2):145-153.
263. Klussmann JP, Muller A, Wagner M, Guntinas-Lichius O, Jungehuelsing M, Sloots T, Ablashi DV, Krueger GR: Human herpesvirus type 8 in salivary gland tumors. J Clin Virol 2000, 16(3):239-246.
264. Meggetto F, Cesarman E, Mourey L, Massip P, Delsol G, Brousset P: Detection and characterization of human herpesvirus-8-infected cells in bone marrow biopsies of human immunodeficiency virus-positive patients. Hum Pathol 2001, 32(3):288-291.
265. Engels EA, Pittaluga S, Whitby D, Rabkin C, Aoki Y, Jaffe ES, Goedert JJ: Immunoblastic lymphoma in persons with AIDS-associated Kaposi's sarcoma: a role for Kaposi's sarcoma-associated herpesvirus. Modern Pathology 2003, 16(5):424-429.
266. Klussmann JP, Wagner M, Guntinas-Lichius O, Muller A: Detection of HHV-8 sequences and antigens in a MALT lymphoma associated with Sjogren's syndrome. Journal of Oral Pathology & Medicine 2003, 32(4):243-245.
267. Cioc AM, Allen C, Kalmar JR, Suster S, Baiocchi R, Nuovo GJ: Oral plasmablastic lymphomas in AIDS patients are associated with human herpesvirus 8.[see comment]. American Journal of Surgical Pathology 2004, 28(1):41-46.
268. Robin YM, Guillou L, Michels JJ, Coindre JM: Human herpesvirus 8 immunostaining: a sensitive and specific method for diagnosing Kaposi sarcoma in paraffin-embedded sections. American Journal of Clinical Pathology 2004, 121(3):330-334.
269. Patel RM, Goldblum JR, Hsi ED: Immunohistochemical detection of human herpes virus-8 latent nuclear antigen-1 is useful in the diagnosis of Kaposi sarcoma. Modern Pathology 2004, 17(4):456-460.
270. Cheuk W, Wong KO, Wong CS, Dinkel JE, Ben-Dor D, Chan JK: Immunostaining for human herpesvirus 8 latent nuclear antigen-1 helps distinguish Kaposi sarcoma from its mimickers. American Journal of Clinical Pathology 2004, 121(3):335-342.
271. Pendergast SD, Werner J, Drevon A, Wiedbrauk DL: Absence of herpesvirus DNA by polymerase chain reaction in ocular fluids obtained from immunocompetent patients. Retina 2000, 20(4):389-393.
272. Wallace HL 2nd, Natelson B, Gause W, Hay J: Human herpesviruses in chronic fatigue syndrome. Clinical & Diagnostic Laboratory Immunology 1999, 6(2):216-223.
273. Kondo K, Hayakawa Y, Mori H, Sato S, Kondo T, Takahashi K, Minamishima Y, Takahashi M, Yamanishi K: Detection by polymerase chain reaction amplification of human herpesvirus 6 DNA in peripheral blood of patients with exanthem subitum. Journal of Clinical Microbiology 1990, 28(5):970-974.
274. Pearson GR: Recommended procedures for the diagnosis of persistent active herpesvirus infections. Journal of Virological Methods 1988, 21(1-4):291-300.
275. Taylor MM, Chohan B, Lavreys L, Hassan W, Huang ML, Corey L, Ashley Morrow R, Richardson BA, Mandaliya K, Ndinya-Achola J, et al.: Shedding of human herpesvirus 8 in oral and genital secretions from HIV-1-seropositive and -seronegative Kenyan women. Journal of Infectious Diseases 2004, 190(3):484-488.
276. Engels EA, Biggar RJ, Marshall VA, Walters MA, Gamache CJ, Whitby D, Goedert JJ: Detection and quantification of Kaposi's sarcoma-associated herpesvirus to predict AIDS-associated Kaposi's sarcoma. Aids 2003, 17(12):1847-1851.
277. Polstra AM, Cornelissen M, Goudsmit J, van der Kuyl AC: Retrospective, longitudinal analysis of serum human herpesvirus-8 viral DNA load in AIDS-related Kaposi's sarcoma patients before and after diagnosis. Journal of Medical Virology 2004, 74(3):390-396.
278. Martro E, Cannon MJ, Dollard SC, Spira TJ, Laney AS, Ou CY, Pellett PE: Evidence for both lytic replication and tightly regulated human herpesvirus 8 latency in circulating mononuclear cells, with virus loads frequently below common thresholds of detection. Journal of Virology 2004, 78(21):11707-11714.
279. Fouchard N, Lacoste V, Couppie P, Develoux M, Mauclere P, Michel P, Herve V, Pradinaud R, Bestetti G, Huerre M, et al.: Detection and genetic polymorphism of human herpes virus type 8 in endemic or epidemic Kaposi's sarcoma from West and Central Africa, and South America. Int J Cancer 2000, 85(2):166-170.
280. Belec L, Mohamed AS, Authier FJ, Hallouin MC, Soe AM, Cotigny S, Gaulard P, Gherardi RK: Human herpesvirus 8 infection in patients with POEMS syndrome-associated multicentric Castleman's disease. Blood 1999, 93(11):3643-3653.
281. Dupon M, Masquelier B, Cazorla C, Chene G, Dumon B, Ragnaud JM, de Barbeyrac B, Bebear C, Lacut JY, Fleury HJ: Acquired immunodeficiency syndrome-associated Kaposi's sarcoma and human herpesvirus 8 DNA detection in serial peripheral blood mononuclear cell samples. Res Virol 1997, 148(6):417-425.
282. Corbellino M, Bestetti G, Scalamogna C, Calattini S, Galazzi M, Meroni L, Manganaro D, Fasan M, Moroni M, Galli M, et al.: Long-term remission of Kaposi sarcoma-associated herpesvirus-related multicentric Castleman disease with anti-CD20 monoclonal antibody therapy. Blood 2001, 98(12):3473-3475.
283. Vieira J, Huang ML, Koelle DM, Corey L: Transmissible Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in saliva of men with a history of Kaposi's sarcoma. J Virol 1997, 71(9):7083-7087.
284. Wakely PE Jr, Menezes G, Nuovo GJ: Primary effusion lymphoma: cytopathologic diagnosis using in situ molecular genetic analysis for human herpesvirus 8. Modern Pathology 2002, 15(9):944-950.
285. Polstra AM, Goudsmit J, Cornelissen M: Development of real-time NASBA assays with molecular beacon detection to quantify mRNA coding for HHV-8 lytic and latent genes. BMC Infectious Diseases 2002, 2(1):18.
286. Polstra AM, Goudsmit J, Cornelissen M: Latent and lytic HHV-8 mRNA expression in PBMCs and Kaposi's sarcoma skin biopsies of AIDS Kaposi's sarcoma patients. Journal of Medical Virology 2003, 70(4):624-627.
287. Cannon MJ, Laney AS, Pellett PE: Human herpesvirus 8: current issues. Clinical Infectious Diseases 2003, 37(1):82-87.
288. Patnaik M, Komaroff AL, Conley E, Ojo-Amaize EA, Peter JB: Prevalence of IgM antibodies to human herpesvirus 6 early antigen (p41/38) in patients with
289. Ablashi DV, Eastman HB, Owen CB, Roman MM, Friedman J, Zabriskie JB, Peterson DL, Pearson GR, Whitman JE: Frequent HHV-6 reactivation in multiple sclerosis (MS) and chronic fatigue syndrome (CFS) patients. J Clin Virol 2000, 16(3):179-191.
290. Shinkura R, Yamamoto N, Koriyama C, Shinmura Y, Eizuru Y, Tokunaga M: Epstein-Barr virus-specific antibodies in Epstein-Barr virus-positive and -negative gastric carcinoma cases in Japan. J Med Virol 2000, 60(4):411-416.
291. Chien YC, Chen JY, Liu MY, Yang HI, Hsu MM, Chen CJ, Yang CS: Serologic markers of Epstein-Barr virus infection and nasopharyngeal carcinoma in Taiwanese men. New England Journal of Medicine 2001, 345(26):1877-1882.
292. Mbopi-Keou FX, Legoff J, Piketty C, Hocini H, Malkin JE, Inoue N, Scully CM, Porter SR, Teo CG, Belec L: Salivary production of IgA and IgG to human herpes virus 8 latent and lytic antigens by patients in whom Kaposi's sarcoma has regressed. Aids 2004, 18(2):338-340.
293. Vornhagen R, Plachter B, Hinderer W, The TH, Van Zanten J, Matter L, Schmidt CA, Sonneborn HH, Jahn G: Early serodiagnosis of acute human cytomegalovirus infection by enzyme-linked immunosorbent assay using recombinant antigens. Journal of Clinical Microbiology 1994, 32(4):981-986.
294. Yamamoto M, Black JB, Stewart JA, Lopez C, Pellett PE: Identification of a nucleocapsid protein as a specific serological marker of human herpesvirus 6 infection. Journal of Clinical Microbiology 1990, 28(9):1957-1962.
295. Ma HJ, Sjak-Shie NN, Vescio RA, Kaminsky M, Mikail A, Pold M, Parker K, Beksac M, Belson D, Moss TJ, et al.: Human herpesvirus 8 open reading frame 26 and open reading frame 65 sequences from multiple myeloma patients: a shared pattern not found in Kaposi's sarcoma or primary effusion lymphoma. Clin Cancer Res 2000, 6(11):4226-4233.